Fig. 1
From: Beneficial effects of curtailing immune susceptibility in an Alzheimer’s disease model
Panel a (table): body, brain, and spleen weight changes in 15-month-old 3xTg-AD mice treated for 12 months with an anti-TNFSF10 monoclonal antibody (10 μg, i.p. twice a month). Panels b–d: comparison of body, brain and spleen weights in the same animals. *p < 0.05 vs WT treated with vehicle; **p < 0.05 vs. untreated 3xTg-AD mice (one-way ANOVA, followed by a Duncan’s multiple range test). Vertical bars are means ± S.E.M. WT wild-type (n = 10/group); AD: 3xTg-AD mice (n = 10/group)